Hisashi Mitsuguchi
Directeur/Bestuurslid bij Karydo TherapeutiX, Inc.
Oorsprong van het eerstegraads netwerk van Hisashi Mitsuguchi
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Karydo TherapeutiX, Inc.
 Karydo TherapeutiX, Inc. Miscellaneous Commercial ServicesCommercial Services Karydo TherapeutiX, Inc. develops technologies to detect the earliest signs of diseases. Its proprietary technology includes “iOrgans Technology.” This technology consists of three sub-technologies: Reverse-iOrgans (R-iOrgans,) Forward-iOrgans (F-iOrgans) and Drug-iOrgans (D-iOrgans.) They all use iOrgans Indicators (iOrgans-Id) to effectively and efficiently detect the earliest signs of diseases (R-iOrgans,) and to pre-empt them (F-iOrgans.) This technology can be also used to discover effects of drugs (D-iOrgans.) The company was founded by Thomas Sato on October 15, 2015 and is headquartered in Tokyo, Japan.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hisashi Mitsuguchi via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| TELLA, INC. | Biotechnology | Director/Board Member | |
| Allgene, Inc. | Director/Board Member | ||
Biomedica Solution KK
 Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Japan | 4 |
Sectoraal
| Health Technology | 3 |
Operationeel
| Director/Board Member | 6 |
| Chairman | 1 |
| Founder | 1 |
| Sales & Marketing | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Takehide Iwasa | 4 |
| Thomas N. Sato | 1 |
| Keiko Sugisaka | 1 |
- Beurs
- Insiders
- Hisashi Mitsuguchi
- Bedrijfsconnecties
